Published in J Clin Invest on May 01, 1976
Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest (1999) 3.36
Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest (1981) 3.34
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest (1980) 3.10
Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest (1987) 2.36
Mechanisms of insulin resistance in aging. J Clin Invest (1983) 2.00
Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest (1987) 1.76
Retracted Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest (1978) 1.73
Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects. J Clin Invest (1976) 1.40
Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents. J Clin Invest (1979) 1.34
Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity. J Clin Invest (1981) 1.30
Evidence for insulin-induced internalization and degradation of insulin receptors in rat adipocytes. Proc Natl Acad Sci U S A (1982) 1.27
Effects of insulin incubation on insulin binding, glucose transport, and insulin degradation by isolated rat adipocytes. Evidence for hormone-induced desensitization at the receptor and postreceptor level. J Clin Invest (1980) 1.26
Increased insulin binding by hepatic plasma membranes from diabetic rats: normalization by insulin therapy. J Clin Invest (1977) 1.19
Glucocorticoid-induced insulin resistance: the importance of postbinding events in the regulation of insulin binding, action, and degradation in freshly isolated and primary cultures of rat hepatocytes. J Clin Invest (1982) 1.15
Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest (2014) 1.13
Insulin signaling in type 2 diabetes: experimental and modeling analyses reveal mechanisms of insulin resistance in human adipocytes. J Biol Chem (2013) 1.11
Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J Clin Invest (1995) 1.11
Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes. J Clin Invest (1987) 1.07
Insulin action and binding in isolated hepatocytes from fasted, streptozotocin-diabetic, and older, spontaneously obese rats. Biochem J (1980) 1.05
Studies of liver insulin receptors in non-obese and obese human subjects. J Clin Invest (1983) 1.01
Short-term overeating induces insulin resistance in fat cells in lean human subjects. Mol Med (2009) 1.00
Insulin signalling mechanisms for triacylglycerol storage. Diabetologia (2013) 1.00
Decreased glucagon receptors in diabetic rat hepatocytes. Evidence for regulation of glucagon receptors by hyperglucagonemia. J Clin Invest (1978) 0.94
Influence of obesity on the antilipolytic effect of insulin in isolated human fat cells obtained before and after glucose ingestion. J Clin Invest (1984) 0.86
Hormonal control of inflammatory responses. Mediators Inflamm (1993) 0.86
Insulin receptors in isolated human adipocytes. Characterization by photoaffinity labeling and evidence for internalization and cellular processing. J Clin Invest (1983) 0.85
125I-8-L-arginine vasopressin binding to human mononuclear phagocytes. J Clin Invest (1981) 0.85
Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy. Proc Natl Acad Sci U S A (1981) 0.84
Pathogenesis of selective insulin resistance in isolated hepatocytes. J Biol Chem (2015) 0.83
Quasi-Steady-State Analysis based on Structural Modules and Timed Petri Net Predict System's Dynamics: The Life Cycle of the Insulin Receptor. Metabolites (2015) 0.79
Glucose transport and metabolism in adipocytes from newly diagnosed untreated insulin-dependent diabetics. Severely impaired basal and postinsulin binding activities. J Clin Invest (1985) 0.78
Obesity: fat cells--not fat people. West J Med (1979) 0.76
Crosstalks via mTORC2 can explain enhanced activation in response to insulin in diabetic patients. Biosci Rep (2016) 0.75
MARCH1 regulates insulin sensitivity by controlling cell surface insulin receptor levels. Nat Commun (2016) 0.75
Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93
METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem (1964) 21.04
Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol (1971) 20.35
Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A (1974) 5.73
Methods for the determination of adipose cell size in man and animals. J Lipid Res (1968) 5.47
Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab (1971) 5.20
Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes. Biochem Biophys Res Commun (1971) 3.74
Insulin interactions with its receptors: experimental evidence for negative cooperativity. Biochem Biophys Res Commun (1973) 3.41
Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance. J Biol Chem (1973) 2.80
Characteristics of the human lymphocyte insulin receptor. J Biol Chem (1973) 2.61
Insulin receptors in human circulating cells and fibroblasts. Proc Natl Acad Sci U S A (1972) 2.24
A simple method to determine fat cell size and number in four mammalian species. Am J Physiol (1971) 2.22
Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction. J Clin Invest (1975) 1.92
Cooperativity in ligand binding: a new graphic analysis. Biochem Biophys Res Commun (1975) 1.87
Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man. Proc Natl Acad Sci U S A (1975) 1.83
The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest (1976) 1.75
Identification and quantitation of thymus-derived lymphocytes in human peripheral blood. J Immunol (1974) 1.73
Insulin receptors in human circulating lymphocytes: application to the study of insulin resistance in man. J Clin Endocrinol Metab (1973) 1.71
Impairment of insulin binding to the fat cell plasma membrane in the obese hyperglycemic mouse. FEBS Lett (1972) 1.71
Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes (1973) 1.60
Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat. J Biol Chem (1974) 1.55
Insulin binding to isolated human adipocytes. Diabetes (1974) 1.53
Effects of age and obesity on insulin binding to isolated adipocytes. Endocrinology (1975) 1.50
Decreased insulin binding to lymphocytes from diabetic subjects. J Clin Invest (1974) 1.37
The human lymphocyte: a model for the study of insulin-receptor interaction. J Clin Endocrinol Metab (1974) 1.25
Insulin receptor: role in the resistance of human obesity to insulin. Science (1975) 1.12
Insulin-induced reduction of membrane receptor concentrations in isolated fat cells and lymphocytes. Independence from receptor occupation and possible relation to proteolytic activity of insulin. J Biol Chem (1975) 0.96
A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. Mol Endocrinol (2000) 4.25
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41
Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J Clin Invest (1981) 3.34
Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes (1996) 3.21
Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest (1980) 3.10
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest (1987) 2.81
Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency. J Clin Invest (2000) 2.67
A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J Biol Chem (1987) 2.48
The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes (1985) 2.46
LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes (1981) 2.40
The insulin receptor: its role in insulin resistance of obesity and diabetes. Diabetes (1976) 2.15
Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? Am J Med (1976) 2.13
Mechanisms of insulin resistance in aging. J Clin Invest (1983) 2.00
Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care (1992) 1.92
In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest (1986) 1.87
Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med (1974) 1.84
Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. J Biol Chem (1994) 1.79
Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest (1987) 1.76
The effects of spontaneous obesity on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest (1976) 1.75
Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling. J Biol Chem (1996) 1.74
Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem (1996) 1.71
Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care (1983) 1.71
Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. J Clin Invest (1975) 1.69
Variance-modeled posterior inference of microarray data: detecting gene-expression changes in 3T3-L1 adipocytes. Bioinformatics (2004) 1.65
Negative feedback regulation and desensitization of insulin- and epidermal growth factor-stimulated p21ras activation. J Biol Chem (1995) 1.65
Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes (1996) 1.60
Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest (1975) 1.59
G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol Cell Biol (1999) 1.58
Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese, and NIDDM subjects. Diabetes (1990) 1.54
Insulin binding to isolated human adipocytes. Diabetes (1974) 1.53
Effects of fasting on insulin binding, glucose transport, and glucose oxidation in isolated rat adipocytes: relationships between insulin receptors and insulin action. J Clin Invest (1976) 1.52
Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1985) 1.51
Mechanisms of the ability of insulin to activate the glucose-transport system in rat adipocytes. Biochem J (1978) 1.51
Effects of streptozotocin-induced diabetes on insulin binding, glucose transport, and intracellular glucose metabolism in isolated rat adipocytes. Diabetes (1979) 1.50
Effects of age and obesity on insulin binding to isolated adipocytes. Endocrinology (1975) 1.50
Insulin binding in diabetes. Relationships with plasma insulin levels and insulin sensitivity. Diabetes (1977) 1.49
Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J Clin Invest (1988) 1.49
Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat. Diabetes (1994) 1.46
Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J Investig Med (1996) 1.45
Interaction of a GRB-IR splice variant (a human GRB10 homolog) with the insulin and insulin-like growth factor I receptors. Evidence for a role in mitogenic signaling. J Biol Chem (1996) 1.45
Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem (1994) 1.43
Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am J Med (1981) 1.43
Effects of lysosomotropic agents on insulin interactions with adipocytes. Evidence for a lysosomal pathway for insulin processing and degradation. J Biol Chem (1979) 1.42
Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus. Diabetes (1986) 1.41
Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem (1987) 1.41
Evidence for recycling of insulin receptors in isolated rat adipocytes. J Biol Chem (1981) 1.38
Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol (1982) 1.38
Decreased insulin binding to lymphocytes from diabetic subjects. J Clin Invest (1974) 1.37
The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem (2000) 1.35
beta -Arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem (2001) 1.35
Relationship between in vivo insulin resistance and decreased insulin receptors in obese man. J Clin Endocrinol Metab (1979) 1.34
Insulin receptor substrate 1 is required for insulin-mediated mitogenic signal transduction. Proc Natl Acad Sci U S A (1994) 1.33
Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest (1985) 1.32
Insulin can regulate GLUT4 internalization by signaling to Rab5 and the motor protein dynein. Proc Natl Acad Sci U S A (2001) 1.31
Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression. Mol Cell Biol (1994) 1.31
Mechanism of the postreceptor defect in insulin action in human obesity. Decrease in glucose transport system activity. J Clin Invest (1981) 1.30
Insulin-stimulated GLUT4 translocation is mediated by a divergent intracellular signaling pathway. J Biol Chem (1995) 1.30
Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes. J Clin Invest (1985) 1.29
Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes. Endocrinology (2000) 1.29
Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport. J Biol Chem (1998) 1.28
Evidence for insulin-induced internalization and degradation of insulin receptors in rat adipocytes. Proc Natl Acad Sci U S A (1982) 1.27
Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes (2001) 1.27
Effects of insulin incubation on insulin binding, glucose transport, and insulin degradation by isolated rat adipocytes. Evidence for hormone-induced desensitization at the receptor and postreceptor level. J Clin Invest (1980) 1.26
Role of glucose transport in the postreceptor defect of non-insulin-dependent diabetes mellitus. Diabetes (1982) 1.26
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab (1992) 1.26
In vitro studies on the action of CS-045, a new antidiabetic agent. Metabolism (1990) 1.26
Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J Biol Chem (2001) 1.24
Shc is the predominant signaling molecule coupling insulin receptors to activation of guanine nucleotide releasing factor and p21ras-GTP formation. J Biol Chem (1994) 1.23
Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action. J Biol Chem (1998) 1.22
The small guanosine triphosphate-binding protein Rab4 is involved in insulin-induced GLUT4 translocation and actin filament rearrangement in 3T3-L1 cells. Endocrinology (1997) 1.21
Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes (1986) 1.20
Membrane-targeted phosphatidylinositol 3-kinase mimics insulin actions and induces a state of cellular insulin resistance. J Biol Chem (1999) 1.20
Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism. Proc Natl Acad Sci U S A (1978) 1.18
Interactions between insulin and its receptors after the initial binding event. Functional heterogeneity and relationships to insulin degradation. Diabetes (1979) 1.18
Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. J Clin Invest (1988) 1.18
Structural differences between insulin receptors in the brain and peripheral target tissues. J Biol Chem (1983) 1.17
Insulin activation of insulin receptor tyrosine kinase in intact rat adipocytes. An in vitro system to measure histone kinase activity of insulin receptors activated in vivo. J Biol Chem (1986) 1.16
Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes. Diabetologia (1977) 1.16
Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects. Diabetes (1998) 1.15
Insulin-stimulated glucose transport in human adipocytes. Am J Physiol (1979) 1.14
Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects. Diabetes (2000) 1.14
Influence of hyperglycemia on insulin's in vivo effects in type II diabetes. J Clin Invest (1984) 1.13
The effects of acute and chronic dexamethasone administration on insulin binding to isolated rat hepatocytes and adipocytes. Metabolism (1975) 1.12
Nuclear translocation of the insulin receptor. A possible mediator of insulin's long term effects. J Biol Chem (1987) 1.11
Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects. Diabetes (1986) 1.10
Regulation of insulin receptors: evidence for involvement of an endocytotic internalization pathway. Proc Natl Acad Sci U S A (1980) 1.10
Surface binding and rates of internalization of 125I-insulin in adipocytes and IM-9 lymphocytes. J Biol Chem (1982) 1.10
Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. Am J Med (1976) 1.09
Mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. Am J Med (1985) 1.08
Biochemical and functional heterogeneity of rat adipocyte glucose transporters. J Biol Chem (1986) 1.08
Insulin receptor kinase activity in rat liver. Regulation by fasting and high carbohydrate feeding. J Biol Chem (1985) 1.08
Kinetics of insulin action in vivo. Identification of rate-limiting steps. Diabetes (1995) 1.08
Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol (1990) 1.08
Effects of insulin and insulin-like agents on the glucose transport system of cultured human fibroblasts. Diabetes (1981) 1.07
Lack of in vivo insulin resistance in controlled insulin-dependent, type I, diabetic patients. J Clin Endocrinol Metab (1984) 1.07
Further evidence that insulin resistance exists in patients with chemical diabetes. Diabetes (1974) 1.07
TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes (1997) 1.06
The functional role of CrkII in actin cytoskeleton organization and mitogenesis. J Biol Chem (1999) 1.06
Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus. J Clin Endocrinol Metab (1983) 1.05